Also found in: Wikipedia.
HUYAHead Up Your Ass
References in periodicals archive ?
SAN DIEGO, March 12, 2015 /PRNewswire/ -- HUYA Bioscience International (HUYA) today announced a key addition to its Executive Team.
Contact details: Clement Gingras CTO and COO, Asia HUYA Bioscience International +1.
With eight offices in China and the largest team of scientists working with Chinese innovators, HUYA identifies and advances promising drug candidates.
Kharkevitch's extensive experience in oncology clinical research and development comes at an important time for HUYA as we advance our lead oncology drug HBI-8000, a novel oral HDAC inhibitor with immunomodulatory properties, through clinical trials," said Mireille Gillings Ph.
CAUPOLICAN Si presumes blandamente, con arrogancia peleas: no me espanto que mi gente huya acobardadamente, ni que haya rey que se atreva a introduccion de ley nueva con vasallo tan valiente (2006-2012).
As we at HUYA are fully aware, launching innovative new products is the most important function of the industry.
With six offices strategically located in China, the most comprehensive Chinese compound portfolio, and a rapidly growing number of exclusive agreements with premier Chinese research and development organizations, HUYA is uniquely positioned to identify and license novel Chinese compounds.
2, 2015 /PRNewswire/ -- HUYA Bioscience International (HUYA), the global leader in accelerating drug discovery and development of biopharma innovation originating in China, recently opened its first Corporate office in Korea.
De ahi que su hijo, Henri Kloz, no soporte la idea de estar recluido en su casa y huya siempre en busca de todo lo que la ciudad le aporta.
MBA Vice President, Marketing, HUYA Bioscience International in San Diego Burnham Trustee Kenneth Woolcott Principal, Six Degrees Capital Consulting Burnham Trustee James Zboril President, Lake Nona Lake Nona site of Burnham's permanent home in Orlando
30, 2015 /PRNewswire/ -- HUYA Bioscience International, the leader in accelerating global development of China's pharmaceutical innovations, today announced it has signed a Memorandum of Understanding with the Korea Drug Development Fund (KDDF) to foster collaboration between KDDF and HUYA with the ultimate goal of advancing Korean development and commercialization of healthcare products for the global market.
At the time, the global pharmaceutical industry often overlooked China as a site for groundbreaking pharmaceutical research -- but Gillings and her HUYA team developed strong relationships with talented Chinese scientists and research organizations to support her overall vision.